RE:Anyone know the margin on Testing Kits? I've lost count of how many times this topic has been addressed. They will not release their margins directly for a variety of reasons, but most importantly so that it doesn't impact future negotiations. You can do your best to crunch the numbers when they release earnings.
Also, I wouldn't say they've "strayed" from their core business; Marshall has already made this clear a few times now that their focus continues to be AI and Nexalogy. Don't be confused over where DM's priorities are, as indicated from the top guy.
infinityholder wrote: I may have missed it in previously reporting or press releasees. Did they disclose what their margins are for the testing kits?
The fact that they strayed from their core business and offerings to re-sell these kits for their Korean partners, would be interested to know how profitable this business actually is.
Looks like they did well in moving in on the market quick and got FDA approval for those kits. Can be quite profitable (but by how much?)